Emotional Exhaustion as Stressor agent for Job Stress in Call Centers: Empirical evidence from perspective of Job Satisfaction and Turnover Intention as Work Outcomes

The purpose of the study is to analyze job burnout component emotional exhaustion as a probable stressor agent that causes job stress and their impact on job satisfaction and turnover intention as work outcomes. The scales were adapted from that measure to analyze the effect of emotional exhaustion causing job stress, also highlights the evidence in support of the conceptual model. Data was collected by the survey that generated 220 respondents. The sample chosen for this research are employees working in telecommunication call centers of Lahore city region in Pakistan. SPSS regression analysis was employed for data analysis. The results showed that emotional exhaustion carried negative and significant relation with job satisfaction (β= -.354,p<.05) and significant positive relation with turnover intention (β= .290, p<.05) also significant relation between dependent variables followed by mediating effect of two dimensions of job stress analyzed by PROCESS procedure of bootstrapping technique contained no and full mediation between emotional exhaustion in relation with job satisfaction and turnover intention respectively. Outcome from the conducted study depicted that stress did not affected the level of satisfaction of employees as they are well trained and informed that job stress is the part of their work activities in call centers and the stress in organizations is needed to be dealt with

The Mediating Role of Emotional Exhaustion in the Relationship between Abusive Supervision and Employee Cyberloafing Behaviour.

Cyberloafing is becoming a common problem in every organization that directly affects organizational productivity. In this study we are going to study the influence of abusive supervision on cyberloafing, further, we are studying the mediating effect of emotional exhaustion generated due to abusive supervision behaviour, motivating employees towards cyberloafing. The data were collected from 150 employees working in Saif Textile Mills Ltd & Kohat Textile Mills Ltd, Pakistan through questionnaires. The study sample was drawn using a convenience sampling technique. This study used SPSS 25 and process Hayes (2013) model 4 for data analysis and for model fitness we used CFA (AMOS 22). The data findings demonstrate that abusive supervision significantly and positively affects cyberloafing and also emotional exhaustion mediates this relation significantly. Therefore we conclude that abusive supervision is the main factor for employees to be exhausted and ultimately move towards cyberloafing. Based on these finding managers plays a vital role to maintain organization environment friendly

How Internship Experience Mediates Career Decision? Insight from Business Institutions

This research paper aims to examine business graduates’ pre-employment decisions relevant to pursue a satisfied and successful career after going through internship training. Subjects were the students who have undergone through an internship program and data was analyzed by using SPSS software. A five point Likert Scale has been used to examine the relation of dependent variable person career (PC) fit and independent variables (job attributes, PO-fit and PJ-fit).The internees degree of perceived pay, benefits, promotion as related to future growth opportunities , job location, peers’ relationship, firm’s image and job duties as major factors and key criterion to pursue a satisfied and successful career .The results also indicate that person job (PJ) fit contributes more than person organization (PO) fit towards person career (PC) fit.Offering internship programs and trainings allows employers the opportunity of exploring full time fresh graduates pool and best talent to recruit

Isolation of thymoquinone from Nigella sativa L. and Thymus vulgaris L., and its anti-proliferative effect on HeLa cancer cell lines

Purpose: To isolate thymoquinone (TQ) from Nigella sativa L. and Thymus vulgaris L., and investigate its anti-proliferative effect on HeLa cancer cells.Method: Pulverized dried samples of N. sativa seed (100 g) and aerial parts of T. vulgaris (1000 g) were subjected to Soxhlet extraction using methanol and n-hexane combined in different proportions. Thymoquinone (TQ) was then isolated from the extracts using high performance liquid chromatography (HPLC). The isolated TQ was further subjected to Fourier Transform Infrared (FTIR) spectroscopy to identify its functional groups. The anti-proliferative effect of TQ on HeLa cancer cells was evaluated using 3-[4, 5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay.Results: Extract yield from N. sativa was significantly higher than from T. vulgaris, and also increased with increase in the proportion of methanol in the extraction solvent (p < 0.05). Methanol and n-hexane (4:1, v:v) yielded the highest amount of oil, with yields of 15.8 and 9.7 ml/25 g dry weight (d.wt.) from N. sativa and T. vulgaris, respectively. The results obtained from HPLC showed that the concentration of TQ isolated from N. sativa (388.61 μg/ml) was significantly higher than that from T. vulgaris (357.03 μg/ml, p < 0.05). The anti-proliferative effects of TQ standard and TQ isolated from N. sativa on HeLa cancer cells were dose-dependent, and was highest at the lowest concentration. The number of viable cells significantly decreased with increase in TQ concentration (p < 0.01). TQ from N. sativa significantly reduced the number of viable cells even at the lowest concentration when compared to TQ standard (p < 0.05). Cell death was significantly higher in TQ-treated groups than in untreated cancer cells.Conclusion: The results obtained in this study show that N. sativa is a potential source of TQ, with the yield enhanced by modifying the extraction procedure or solvent used. Furthermore, TQ isolated from N. sativa exerts a dose-dependent anti-proliferative effect on HeLa cancer cells.Keywords: Thymoquinone, Nigella sativa, Thymus vulgaris, Anti-proliferative effec

Unveiling and addressing implementation barriers to routine immunization in the peri-urban slums of Karachi, Pakistan: A mixed-methods study

Background: Great disparities in immunization coverage exist in Pakistan between urban and rural areas. However, coverage estimates for large peri-urban slums in Sindh are largely unknown and implementation challenges remain unexplored. This study explores key supply- and demand-side immunization barriers in peri-urban slums, as well as strategies to address them. It also assesses immunization coverage in the target slums.Methods: Conducted in four peri-urban slums in Karachi, this mixed-methods study consists of a baseline cross-sectional coverage survey of a representative sample of 840 caregivers of children aged 12-23 months, and 155 in-depth interviews (IDIs) through purposive sampling of respondents (caregivers, community influencers and immunization staff). After identifying the barriers, a further six IDIs were then conducted with immunization policy-makers and policy influencers to determine strategies to address these barriers, resulting in the development of an original validated implementation framework for immunization in peri-urban slums. A thematic analysis approach was applied to qualitative data.Results: The survey revealed 49% of children were fully vaccinated, 43% were partially vaccinated and 8% were unvaccinated. Demand-side immunization barriers included household barriers, lack of knowledge and awareness, misconceptions and fears regarding vaccines and social and religious barriers. Supply-side barriers included underperformance of staff, inefficient utilization of funds, unreliable immunization and household data and interference of polio campaigns with immunization. The implementation framework\u27s policy recommendations to address these barriers include: (1) improved human resource management; (2) staff training on counselling; (3) re-allocation of funds towards incentives, outreach, salaries and infrastructure; (4) a digital platform integrating birth registry and vaccination tracking systems for monitoring and reporting by frontline staff; (5) use of digital platform for immunization targets and generating dose reminders; and (6) mutual sharing of resources and data between the immunization, Lady Health Worker and polio programmes for improved coverage.Conclusions: The implementation framework is underpinned by the study of uncharted immunization barriers in complex peri-urban slums, and can be used by implementers in Pakistan and other developing countries to improve immunization programmes in limited-resource settings, with possible application at a larger scale. In particular, a digital platform integrating vaccination tracking and birth registry data can be expanded for nationwide use

Exploring the Learning Styles of Postgraduates in a Public-Sector University at Karachi

Introduction: Learning styles is a term used to refer to the methods of gathering, processing, interpreting, organizing and thinking about information. Knowledge of the learning styles can be helpful in making teaching and learning process more efficient. Little is mentioned in medical education literature in Pakistan about the learning styles knowledge in deciphering the teaching and learning process. Objective: To identify the distribution of the learning styles among the postgraduate students and to find ways to improve the way the courses, the practical hours and training are performed. Methodology: The current study analyses the learning styles of post graduate students of Dow University of Health Sciences Karachi to guide facilitator as well as students in organizing their teaching sessions more efficiently and maximize the utility of educational resources with subsequent improvement in educational process. During Jan 2016 to Dec 2016, this cross-sectional study using Kolb’s learning inventory as the instrument to find out the learning styles was conducted among post-graduates’ students of a public-sector university by using English language versions of Learning Style Inventory (LSI)of 216 post-graduates ‘students. Results: According to observation and data analysis by Kolb’s learning Styles Inventory most of the postgraduates had their learning style reflector (Diverger). However, some were Theorist (Assimilators) and then very few were Activist (Accommodator) and Pragmatist (Converser) respectively. Conclusions: Differences in the learning styles and learning approaches have important implications in development of effective medical curricula in post graduate medical education.  Key words: Learning style, Postgraduate students, medical educatio

Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial

Background: Parenteral antibiotic therapy for young infants (aged 0–59 days) with suspected sepsis is sometimes not available or feasible in countries with high neonatal mortality. Outpatient treatment could save lives in such settings. We aimed to assess the equivalence of two simplified antibiotic regimens, comprising fewer injections and oral rather than parenteral administration, compared with a reference treatment for young infants with clinical severe infection.Methods: We undertook the Simplified Antibiotic Therapy Trial (SATT), a three-arm, randomised, open-label, equivalence trial in five communities in Karachi, Pakistan. We enrolled young infants (aged 0–59 days) who either presented at a primary health-care clinic or were identified by a community health worker with signs of clinical severe infection. We included infants who were not critically ill and whose family refused admission. We randomly assigned infants to either intramuscular procaine benzylpenicillin and gentamicin once a day for 7 days (reference); oral amoxicillin twice daily and intramuscular gentamicin once a day for 7 days; or intramuscular procaine benzylpenicillin and gentamicin once a day for 2 days followed by oral amoxicillin twice daily for 5 days. The primary outcome was treatment failure within 7 days of enrolment and the primary analysis was per protocol. We judged experimental treatments as efficacious as the reference if the upper bound of the 95% CI for the difference in treatment failure was less than 5·0. This trial is registered at ClinicalTrials.gov , numberNCT01027429 . Findings: Between Jan 1, 2010, and Dec 26, 2013, 2780 infants were deemed eligible for the trial, of whom 2453 (88%) were enrolled. Because of inadequate clinical follow-up or treatment adherence, 2251 infants were included in the per-protocol analysis. 820 infants (747 per protocol) were assigned the reference treatment of procaine benzylpenicillin and gentamicin, 816 (751 per protocol) were allocated amoxicillin and gentamicin, and 817 (753 per protocol) were assigned procaine benzylpenicillin, gentamicin, and amoxicillin. Treatment failure within 7 days of enrolment was reported in 90 (12%) infants who received procaine benzylpenicillin and gentamicin (reference), 76 (10%) of those given amoxicillin and gentamicin (risk difference with reference −1·9, 95% CI −5·1 to 1·3), and 99 (13%) of those treated with procaine benzylpenicillin, gentamicin, and amoxicillin (risk difference with reference 1·1, −2·3 to 4·5). Interpretation: Two simplified antibiotic regimens requiring fewer injections are equivalent to a reference treatment for young infants with signs of clinical severe infection but without signs of critical illness. The use of these simplified regimens has the potential to increase access to treatment for sick young infants who cannot be referred to hospital

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia

Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population idiopathic acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using G acquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using Gacquired aplastic anemia at the time of diagnosis, using G-banding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysis banding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysis banding cytogenetic analysisbanding cytogenetic analysisbanding cytogenetic analysis banding cytogenetic analysis.Patients and Methods: This cross sectional study was conducted in Department of Haematology, Pakistan Institute of Medical Sciences, and Islamabad and Department of Genetics, Children Hospital, Lahore from June 2015 to July 2017. Sample size was calculated using WHO sample size calculator. A total of sixty cases of peripheral blood pancytopenia having clinical suspicion of acquired aplastic anemia and diagnosed on bone marrow examination with aplastic anemia were included in the study. Bone marrow or peripheral blood samples were also processed for cytogenetics by G-banding and karyotyping according to International System for Human Cytogenetic Nomenclature (ISCN) to determine frequency of chromosomal abnormalities in the patients of acquired aplastic anaemia.Results: Sixty cases diagnosed to have acquired aplastic anaemia using bone marrow examination as gold standard were included in the study based on inclusion criteria. Forty-five out of 60 patients (75%) had successful karyotyping whereas 15 out of 60 patients (25%) had inconclusive cytogenetics due to culture failure, inadequate metaphase cells and contamination. G-banding revealed normal karyotyping in 40 out of 45 patients (88.9%) while 5 out of 45 patients (11.1%) were found to have abnormal karyotyping. Chromosomal abnormalities revealed by abnormal karyotyping included three numerical abnormalities i.e. monosomy 7, trisomy 8, trisomy 14 and two structural abnormalities i.e. deletion of 11q, deletion of 13q. The frequency of chromosomal abnormalities in patients with acquired aplastic anaemia in this study was found to be 11.1%.Conclusion: Cytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic ytogenetic analysis may be beneficial in differentiating acquired AA from other haemopoietic disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morphology alone. It also guides in disorders of bone marrow failure, which may be missed, based on cell morp